Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease

被引:91
作者
Donath, Marc Y. [1 ,2 ]
Meier, Daniel T. [1 ,2 ]
Boni-Schnetzler, Marianne [1 ,2 ]
机构
[1] Univ Basel, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland
[2] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
NECROSIS-FACTOR-ALPHA; ISLET AMYLOID POLYPEPTIDE; IL-1 RECEPTOR ANTAGONIST; BETA-CELL PROLIFERATION; OBESITY-INDUCED INFLAMMATION; C-REACTIVE PROTEIN; INSULIN SENSITIVITY; NLRP3; INFLAMMASOME; CARDIOVASCULAR OUTCOMES; RHEUMATOID-ARTHRITIS;
D O I
10.1210/er.2019-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of chronic inflammation in the pathogenesis of type 2 diabetes mellitus and associated complications is now well established. Therapeutic interventions counteracting metabolic inflammation improve insulin secretion and action and glucose control and may prevent long-term complications. Thus, a number of anti-inflammatory drugs approved for the treatment of other inflammatory conditions are evaluated in patients with metabolic syndrome. Most advanced are clinical studies with IL-1 antagonists showing improved beta-cell function and glycemia and prevention of cardiovascular diseases and heart failure. However, alternative anti-inflammatory treatments, alone or in combinations, may turn out to be more effective, depending on genetic predispositions, duration, and manifestation of the disease. Thus, there is a great need for comprehensive and well-designed clinical studies to implement anti-inflammatory drugs in the treatment of patients with metabolic syndrome and its associated conditions.
引用
收藏
页码:1080 / 1091
页数:12
相关论文
共 151 条
[1]   Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment [J].
Amar, Jacques ;
Chabo, Chantal ;
Waget, Aurelie ;
Klopp, Pascale ;
Vachoux, Christelle ;
Bermudez-Humaran, Luis G. ;
Smirnova, Natalia ;
Berge, Mathieu ;
Sulpice, Thierry ;
Lahtinen, Sampo ;
Ouwehand, Arthur ;
Langella, Philippe ;
Rautonen, Nina ;
Sansonetti, Philippe J. ;
Burcelin, Remy .
EMBO MOLECULAR MEDICINE, 2011, 3 (09) :559-572
[2]   Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor α therapy [J].
Antohe, Jana L. ;
Bili, Androniki ;
Sartorius, Jennifer A. ;
Kirchner, H. Lester ;
Morris, Stephanie J. ;
Dancea, Sorina ;
Wasko, Mary Chester M. .
ARTHRITIS CARE & RESEARCH, 2012, 64 (02) :215-221
[3]   IL-37 protects against obesity-induced inflammation and insulin resistance [J].
Ballak, Dov B. ;
van Diepen, Janna A. ;
Moschen, Alexander R. ;
Jansen, Henry J. ;
Hijmans, Anneke ;
Groenhof, Gert-Jan ;
Leenders, Floris ;
Bufler, Philip ;
Boekschoten, Mark V. ;
Muller, Michael ;
Kersten, Sander ;
Li, Suzhao ;
Kim, SooHyun ;
Eini, Hadar ;
Lewis, Eli C. ;
Joosten, Leo A. B. ;
Tilg, Herbert ;
Netea, Mihai G. ;
Tack, Cees J. ;
Dinarello, Charles A. ;
Stienstra, Rinke .
NATURE COMMUNICATIONS, 2014, 5
[4]   The spectrum of T cell metabolism in health and disease [J].
Bantug, Glenn R. ;
Galluzzi, Lorenzo ;
Kroemer, Guido ;
Hess, Christoph .
NATURE REVIEWS IMMUNOLOGY, 2018, 18 (01) :19-34
[5]   Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression [J].
Bauernfeind, Franz G. ;
Horvath, Gabor ;
Stutz, Andrea ;
Alnemri, Emad S. ;
MacDonald, Kelly ;
Speert, David ;
Fernandes-Alnemri, Teresa ;
Wu, Jianghong ;
Monks, Brian G. ;
Fitzgerald, Katherine A. ;
Hornung, Veit ;
Latz, Eicke .
JOURNAL OF IMMUNOLOGY, 2009, 183 (02) :787-791
[6]   CYTOTOXICITY OF HUMAN PI-7 INTERLEUKIN-1 FOR PANCREATIC-ISLETS OF LANGERHANS [J].
BENDTZEN, K ;
MANDRUPPOULSEN, T ;
NERUP, J ;
NIELSEN, JH ;
DINARELLO, CA ;
SVENSON, M .
SCIENCE, 1986, 232 (4757) :1545-1547
[7]   Effects of etanercept in patients with the metabolic syndrome [J].
Bernstein, LE ;
Berry, J ;
Kim, S ;
Canavan, B ;
Grinspoon, SK .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (08) :902-908
[8]   Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I [J].
Boeni-Schnetzler, Marianne ;
Boller, Simone ;
Debray, Sarah ;
Bouzakri, Karim ;
Meier, Daniel T. ;
Prazak, Richard ;
Kerr-Conte, Julie ;
Pattou, Francois ;
Ehses, Jan A. ;
Schuit, Frans C. ;
Donath, Marc Y. .
ENDOCRINOLOGY, 2009, 150 (12) :5218-5229
[9]   Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation [J].
Boni-Schnetzler, Marianne ;
Thorne, Jeffrey ;
Parnaud, Geraldine ;
Marselli, Lorella ;
Ehses, Jan A. ;
Kerr-Conte, Julie ;
Pattou, Francois ;
Halban, Philippe A. ;
Weir, Gordon C. ;
Donath, Marc Y. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) :4065-4074
[10]   β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion [J].
Boni-Schnetzler, Marianne ;
Hauselmann, Stephanie P. ;
Dalmas, Elise ;
Meier, Daniel T. ;
Thienel, Constanze ;
Traub, Shuyang ;
Schulze, Friederike ;
Steiger, Laura ;
Dror, Erez ;
Martin, Praxedis ;
Herrera, Pedro L. ;
Gabay, Cem ;
Donath, Marc Y. .
CELL REPORTS, 2018, 22 (07) :1774-1786